Geode Capital Management, LLC Protalix Bio Therapeutics, Inc. Transaction History
Geode Capital Management, LLC
- $1.39 Trillion
- Q2 2025
A detailed history of Geode Capital Management, LLC transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 826,333 shares of PLX stock, worth $1.98 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
826,333Holding current value
$1.98 Million% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding PLX
# of Institutions
69Shares Held
8.72MCall Options Held
168KPut Options Held
31.4K-
Jim Simons Renaissance Technologies LLC | New York, Ny1.62MShares$3.88 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL1.08MShares$2.59 Million0.0% of portfolio
-
Connor, Clark & Lunn Investment Management Ltd.496KShares$1.19 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA485KShares$1.16 Million0.0% of portfolio
-
Morgan Stanley New York, NY462KShares$1.11 Million0.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $119M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...